Daniel P. Sherbet, MD

Original Contribution

The AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusion (ACE-CTO) Study

09/02/2015

Calin Maniu , MD;

Shuaib M. Abdullah , MD;

Michele Roesle , RN, BSN, MD;

Jeffrey L. Hastings , MD, MS;

Bavana V. Rangan , BDS, MPH, MD;

Dharam J. Kumbhani , MD, SM;

Michael Luna , MD;

Tayo Addo , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Subhash Banerjee , MD, FSCAI;

Santiago Garcia , MD;

Ashish Pershad , MD;

Anna P. Kotsia , MD, PhD;

Georgios Christopoulos , MD;

Rachita Navara , MD;

Tesfaldet T. Michael , MD, MPH;

Daniel P. Sherbet , MD;

Donald Haagen , RCIS, MD;

There are limited data on outcomes after implantation of second-generation drug-eluting stents in coronary chronic total occlusions (CTOs). This study aimed to evaluate the frequency of angiographic restenosis and clinical outcomes after...

There are limited data on outcomes after implantation of second-generation drug-eluting stents in coronary chronic total occlusions (CTOs). This study aimed to evaluate the frequency of angiographic restenosis and clinical outcomes after...

There are limited data on...

09/02/2015

Journal of Invasive Cardiology

Original Contribution

Prevalence and Treatment of "Balloon-Uncrossable" Coronary Chronic Total Occlusions

02/01/2015

Rohan V. Menon , BS , MD;

Siddharth M. Patel , MD, BS;

Nagendra R. Pokala , BS;

Vijay Raja , MD;

Bavana V. Rangan , BDS, MPH, MD;

Jerrold M. Grodin , MD;

Anna P. Kotsia , MD, PhD;

Georgios Christopoulos , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Tesfaldet T. Michael , MD, MPH;

Daniel P. Sherbet , MD;

Jeffrey L. Hastings , MD, MS;

Vishal G. Patel , MD;

Subhash Banerjee , MD, FSCAI;

Shuaib A. Abdullah , MD;

We retrospectively examined 373 consecutive CTO-PCIs performed at our institution between 2005 and 2013 to determine the frequency and treatment of balloon-uncrossable CTOs. Balloon-uncrossable CTOs are encountered in 6.4% of contemporary...

We retrospectively examined 373 consecutive CTO-PCIs performed at our institution between 2005 and 2013 to determine the frequency and treatment of balloon-uncrossable CTOs. Balloon-uncrossable CTOs are encountered in 6.4% of contemporary...

We retrospectively examined 373...

02/01/2015

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

April 30 ⁠–⁠ May 5

WoundCon

May 1 ⁠–⁠ May 3

May 19 ⁠–⁠ May 21

See Full Calendar